Everett & Hurite Ophthalmic Association

Vivasc Therapeutics Inc., based in Pittsburgh, PA, specializes in innovative drug delivery systems focused on reversing the effects of heart failure and treating atrial fibrillation. Utilizing their proprietary Cardiac Targeting Peptide, they aim to deliver therapeutic agents specifically to cardiomyocytes, addressing underlying cellular dysfunction rather than merely alleviating symptoms associated with heart diseases. Founded in 2020, the company has engaged in several STTR Phase I projects, demonstrating significant advancements in delivery methods for treatment options like miRNA and amiodarone, designed to target heart tissues with precision. Their research holds promise for improving patient outcomes by mitigating adverse effects commonly related to current heart failure and arrhythmia treatments. Generated from the website

Magee-Womens Research Institute and Foundation is the largest research institute in the U.S. dedicated solely to women's health research. With a focus on advancing knowledge and improving outcomes in women's health, the institute conducts groundbreaking research to address the unique health needs of women. Through its innovative research initiatives, Magee-Womens Research Institute and Foundation plays a pivotal role in shaping the future of women's healthcare. Committed to driving progress in women's health, the institute is at the forefront of cutting-edge research and discovery in the field. Generated from their website's infomation